Evaluation to the chemotherapy use in patients with diffuse large B-cell lymphoma
-
Dirani Dirani
,
Made Sedana
Abstract
Background
Non-Hodgkin lymphoma (NHL) is a large group of primary malignancies of solid lymphoid tissue. Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of NHL. DLBCL has an aggressive natural history but responds well to chemotherapy. The objective of this study was to review the use of chemotherapy, identify its side effects, and examine the response to chemotherapy in patients with NHL at Dr. Soetomo General Hospital.
Methods
This study was a retrospective observational study using secondary data obtained from patients’ medical records from 2016 to 2018. Demographic data (age, sex), clinical characteristics, chemotherapy regimens, side effects of chemotherapy, and response to chemotherapy were recorded.
Results
Results revealed that of the 43 patients (age ranged from 21 to 80 years) who were included in this study, the prevalence of DLBCL was higher in male patients (74%) and about 44% patients were at stage III. R-CHOP (rituximab-cyclophosphamide, doxorubicin, vincristine/oncovin, prednisone) (53%) was the most used chemotherapy regimen in this study. A total of 65% of patients showed good responses and 35% showed no response to the therapy. The most common side effect was myelosuppression, including 25% and 8% of the patients having anemia and leukopenia, respectively.
Conclusions
R-CHOP is the most used regimen. Most of patients with NHL have a complete response and the predominant side effect is anemia.
Acknowledgment
The author thanks the Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Airlangga.
Research funding: The author thanks to Tahir Professorship program from Tahir Foundation.
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Competing interests: Authors state no conflict of interest.
Informed consent: Informed consent was obtained from all individuals included in this study.
Ethical approval: Research involving human subjects complied with all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013), and has been approved by the authors’ institutional review board.
References
[1] Fausel C. Chapter 90: Malignant Lhymphomas. In: Chishol-Burns MA, Wells BG, Schwinghammer TL, Malone PM, Kolesar JM, Rotschafer J, et al., editors. Pharmacotherapy principle and practice. USA: The McGraw-Hill Education, 2008:1371–84.Search in Google Scholar
[2] Hecht KA, Liewer SE. Malignant Lymphomas. In: Chisholm-Burns MA, Schwinghammer TL, Wells BG, Malone PM, Kolesar JM, Dipiro JT, editors. Pharmacotherapy principles and practice, 4th ed. New York: The McGraw-Hill Education, 2016:1433–59.Search in Google Scholar
[3] American Cancer Society. 2018. Chemotherapy for non-Hodgkin lymphoma. American Cancer Society. Available at: https://www.cancer.org/cancer/non-hodgkin-lymphoma.html. Accessed: 28 Oct 2018.Search in Google Scholar
[4] Dark GG. The global burden of cancer. In: Dark GG, editor. Oncology at a glance, 1st ed. UK: John Wiley & Sons, Ltd, 2013:10–11.Search in Google Scholar
[5] Kementerian Kesehatan Republik Indonesia. Data dan Kondisi Penyakit Limfoma di Indonesia. Jakarta: Kementerian Kesehatan Republik Indonesia, 2015:1–4.Search in Google Scholar
[6] Reksodiputro AH. Multicentre epidemiology and survival study of B cell non Hodgkin lymphoma patients in Indonesia. J Blood Disorder Transfusion 2015;6:1–5.10.4172/2155-9864.1000257Search in Google Scholar
[7] Jacobson JO, Polovich M, Gilmore TR, Schulmeister L, Esper P, LeFebvre KB, et al. Revisions to the 2009 American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards: expanding the scope to include inpatient settings. Oncol Nurs Forum 2012;39:31–8.10.1188/12.ONF.31-38Search in Google Scholar PubMed
[8] Mansi J. Generic chemotherapy protocol guidelines. London, England: NHS South East London Cancer Network, 2013:3–5.Search in Google Scholar
[9] NCCN. Non-Hodgkin’s Lymphomas. London, England: National Comprehensive Cancer Network, 2014:58–70.Search in Google Scholar
[10] Castillo JJ, Ghobrial IM, Treon SP. Biology, prognosis, and therapy of Waldenström macroglobulinemia. Cancer Treat Res 2015;165:177–96.10.1007/978-3-319-13150-4_7Search in Google Scholar PubMed
[11] Ondrejka SL, Hsi ED. Pathology of B-cell lymphomas: diagnosis and biomarker discovery. Cancer Treat Res 2015;165:1–26.10.1007/978-3-319-13150-4_2Search in Google Scholar PubMed
[12] Winkfield KM, Tsang RW, Gospodarowicz MK. Chapter 77: non-hodgkin’s lymphoma. In: Winkfield KM, Tsang RW, Gospodarowicz MK, editors. Clinical radiation oncology. Philadephia: Elsevier; 2016:1524–46.10.1016/B978-0-323-24098-7.00077-0Search in Google Scholar
[13] Jaffe ES, Pittaluga S, Anastasi J. Chapter 73: the pathologic basis for the classification of non-hodgkin and hodgkin lymphomas. In: Hoffman R, Benz EJ, Silberstein LE, Heslop H, Weitz J, Anastasi J, editors. Hematology: diagnosis and treatment. Philadephia: Elsevier, 2018:1187–203.10.1016/B978-0-323-35762-3.00073-1Search in Google Scholar
[14] Rubenstein JL, Gupta NK, Mannis GN, LaMarre AK, Treseler P. How I treat CNS lymphoma. American Society of Hematology. Blood 2013;122:3061–7.10.1182/blood-2013-06-453084Search in Google Scholar
[15] ASCO. 2015. Understanding Targeted Therapy. American Society of Clinical Oncology. Available at: www.cancer.net/navigating-cancer-care/hoe-cancertreated/personalized-and-targeted-theraphies/understanding-targeted-therapy. Accessed: 30 Oct 2018.Search in Google Scholar
[16] Chiu BC, Hou N. Epidemiology and etiology of non-Hodgkin lymphoma. Cancer Treat Res 2015;165:1–26.10.1007/978-3-319-13150-4_1Search in Google Scholar PubMed
[17] Salma RS, Bintoro UY, Sedana MP. CHOP and R-CHOP therapeutic responses in non-Hodgkin lymphoma patients in Dr. Soetomo General Hospital Surabaya. Biomol Health Sci J 2018;2:93–6.10.20473/bhsj.v1i2.9244Search in Google Scholar
[18] BCCA. BC cancer agency cancer drug manual, doxorubicin. London, England: BC Cancer Agency, 2017:1–9.Search in Google Scholar
[19] Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendation for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 2014;32:3059–67.10.1200/JCO.2013.54.8800Search in Google Scholar PubMed PubMed Central
[20] Gordon KA, Tosti A. Alopecia: evaluation and treatment. Clin Cosmet Investig Dermatol 2011;4:101–6.10.2147/CCID.S10182Search in Google Scholar PubMed PubMed Central
© 2019 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Reviews
- Pharmacist contributions in the treatment of diabetes mellitus in Southeast Asia: a narrative review
- The implementation of a chronic disease management program (Prolanis) in Indonesia: a literature review
- Original Articles
- Quercetin attenuates acute predator stress exposure-evoked innate fear and behavioral perturbation
- Evaluating current practices and policies in the use of injectable medicines for treating myalgia in a primary care center in Pamekasan, Indonesia
- The contemporary role and potential of pharmacist contribution for community health using social media
- Evaluation of rational drug use based on World Health Organization prescribing indicators in a primary care center in Pamekasan East Java, Indonesia
- The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting
- Factors affecting community pharmacist’s service for women with chronic diseases during pregnancy and breastfeeding: application of the Health Belief Model
- Overview of therapeutic changes in antiepileptic drugs in adult patients
- Exploration of barriers affecting job satisfaction among community pharmacists
- Patients’ characteristics and their adherence to insulin therapy
- Correlation of chemotherapy costs with quality of life in nasopharyngeal cancer patients
- Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia
- Translation, cultural adaptation, and validation of the quality of well being self-administered questionnaire in general population in Indonesia
- Knowledge, attitude, and practice of pharmacists towards management of hypertension in primary care centers
- Medication adherence in diabetes mellitus patients at Tanjung Karang Primary Health Care Center, Mataram
- Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2
- Antiaggregation effect of clopidogrel in coronary heart disease patients using omeprazole
- The effect of curcuma (Curcuma xanthorrizha roxb.) extract as an adjuvant of captopril therapy on cardiac histopathology of male mice (Mus musculus) with hypertension
- Coenzyme Q10 nanostructured lipid carriers as an inducer of the skin fibroblast cell and its irritability test in a mice model
- Medical problems in patients with chronic kidney disease undergoing hemodialysis and their therapy
- ADMET properties of novel 5-O-benzoylpinostrobin derivatives
- Development of nonalcoholic fatty liver disease model by high-fat diet in rats
- Molecular docking of novel 5-O-benzoylpinostrobin derivatives as wild type and L858R/T790M/V948R mutant EGFR inhibitor
- The relationship between the level of education and accuracy of insulin injection techniques in DM patients with measurement of HbA1c values
- The effect of premixed insulin to blood glucose concentration in patients with type 2 diabetes mellitus
- Intravenous insulin therapy in diabetes mellitus with hyperglycemic crisis and intercurrent illness
- Adherence behavior assessment of oral antidiabetic medication use: a study of patient decisions in long-term disease management in primary health care centers in Surabaya
- Evaluation to the chemotherapy use in patients with diffuse large B-cell lymphoma
- Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients
- Antineuroinflammation activity of n-butanol fraction of Marsilea crenata Presl. in microglia HMC3 cell line
- The enhancement of Arg1 and activated ERβ expression in microglia HMC3 by induction of 96% ethanol extract of Marsilea crenata Presl. leaves
- Ternary solid dispersion to improve solubility and dissolution of meloxicam
- Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide
- o-Hydroxycinnamic derivatives as prospective anti-platelet candidates: in silico pharmacokinetic screening and evaluation of their binding sites on COX-1 and P2Y12 receptors
- The change of proinflammatory cytokine tumor necrosis factor α level in the use of meloxicam in rat model of osteoarthritis
- Attenuation of IL-1ß on the use of glucosamine as an adjuvant in meloxicam treatment in rat models with osteoarthritis
- Analysis of effectiveness and drug related problems of pain reliever for knee osteoarthritis: weighing clinical risk and benefit
- Comparison of antibiotic prescriptions in adults and children with upper respiratory tract infections in Bangka Tengah primary health care centers
- Profile of sociodemographics, sources of infection, antiretrovirals and CD4 counts on HIV/AIDS outpatients in Turen Primary Health Centre, Indonesia
- Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor
- In vitro equivalence of generic and branded amoxicillin tablet by microbiological assay method
- Knowledge and attitude: two fundamental factors that determine patient compliance in antibiotic therapy
- Molecular docking study of sappan wood extract to inhibit PBP2A enzyme on methicillin-resistant Staphylococcus aureus (MRSA)
- Effect of curcumin analogue synthetic product from cullilawan oil for the liver damage treatment in male mice (Mus musculus L.)
- Case Report
- A case report of generalized tetanus in a 42-year-old man with dental infection
Articles in the same Issue
- Reviews
- Pharmacist contributions in the treatment of diabetes mellitus in Southeast Asia: a narrative review
- The implementation of a chronic disease management program (Prolanis) in Indonesia: a literature review
- Original Articles
- Quercetin attenuates acute predator stress exposure-evoked innate fear and behavioral perturbation
- Evaluating current practices and policies in the use of injectable medicines for treating myalgia in a primary care center in Pamekasan, Indonesia
- The contemporary role and potential of pharmacist contribution for community health using social media
- Evaluation of rational drug use based on World Health Organization prescribing indicators in a primary care center in Pamekasan East Java, Indonesia
- The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting
- Factors affecting community pharmacist’s service for women with chronic diseases during pregnancy and breastfeeding: application of the Health Belief Model
- Overview of therapeutic changes in antiepileptic drugs in adult patients
- Exploration of barriers affecting job satisfaction among community pharmacists
- Patients’ characteristics and their adherence to insulin therapy
- Correlation of chemotherapy costs with quality of life in nasopharyngeal cancer patients
- Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia
- Translation, cultural adaptation, and validation of the quality of well being self-administered questionnaire in general population in Indonesia
- Knowledge, attitude, and practice of pharmacists towards management of hypertension in primary care centers
- Medication adherence in diabetes mellitus patients at Tanjung Karang Primary Health Care Center, Mataram
- Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2
- Antiaggregation effect of clopidogrel in coronary heart disease patients using omeprazole
- The effect of curcuma (Curcuma xanthorrizha roxb.) extract as an adjuvant of captopril therapy on cardiac histopathology of male mice (Mus musculus) with hypertension
- Coenzyme Q10 nanostructured lipid carriers as an inducer of the skin fibroblast cell and its irritability test in a mice model
- Medical problems in patients with chronic kidney disease undergoing hemodialysis and their therapy
- ADMET properties of novel 5-O-benzoylpinostrobin derivatives
- Development of nonalcoholic fatty liver disease model by high-fat diet in rats
- Molecular docking of novel 5-O-benzoylpinostrobin derivatives as wild type and L858R/T790M/V948R mutant EGFR inhibitor
- The relationship between the level of education and accuracy of insulin injection techniques in DM patients with measurement of HbA1c values
- The effect of premixed insulin to blood glucose concentration in patients with type 2 diabetes mellitus
- Intravenous insulin therapy in diabetes mellitus with hyperglycemic crisis and intercurrent illness
- Adherence behavior assessment of oral antidiabetic medication use: a study of patient decisions in long-term disease management in primary health care centers in Surabaya
- Evaluation to the chemotherapy use in patients with diffuse large B-cell lymphoma
- Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients
- Antineuroinflammation activity of n-butanol fraction of Marsilea crenata Presl. in microglia HMC3 cell line
- The enhancement of Arg1 and activated ERβ expression in microglia HMC3 by induction of 96% ethanol extract of Marsilea crenata Presl. leaves
- Ternary solid dispersion to improve solubility and dissolution of meloxicam
- Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide
- o-Hydroxycinnamic derivatives as prospective anti-platelet candidates: in silico pharmacokinetic screening and evaluation of their binding sites on COX-1 and P2Y12 receptors
- The change of proinflammatory cytokine tumor necrosis factor α level in the use of meloxicam in rat model of osteoarthritis
- Attenuation of IL-1ß on the use of glucosamine as an adjuvant in meloxicam treatment in rat models with osteoarthritis
- Analysis of effectiveness and drug related problems of pain reliever for knee osteoarthritis: weighing clinical risk and benefit
- Comparison of antibiotic prescriptions in adults and children with upper respiratory tract infections in Bangka Tengah primary health care centers
- Profile of sociodemographics, sources of infection, antiretrovirals and CD4 counts on HIV/AIDS outpatients in Turen Primary Health Centre, Indonesia
- Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor
- In vitro equivalence of generic and branded amoxicillin tablet by microbiological assay method
- Knowledge and attitude: two fundamental factors that determine patient compliance in antibiotic therapy
- Molecular docking study of sappan wood extract to inhibit PBP2A enzyme on methicillin-resistant Staphylococcus aureus (MRSA)
- Effect of curcumin analogue synthetic product from cullilawan oil for the liver damage treatment in male mice (Mus musculus L.)
- Case Report
- A case report of generalized tetanus in a 42-year-old man with dental infection
